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Abstract
Objective To evaluate the effect of anesthesia type on the risk of
in-hospital mortality among adults undergoing hip fracture surgery in the
United States.
Design Retrospective cohort study.
Setting Premier research database, United States.
Participants 73 284 adults undergoing hip fracture surgery on hospital
day 2 or greater between 2007 and 2011. Of those, 61 554 (84.0%)
received general anesthesia, 6939 (9.5%) regional anesthesia, and 4791
(6.5%) combined general and regional anesthesia.
Main outcome measure In-hospital all cause mortality.
Results In-hospital deaths occurred in 1362 (2.2%) patients receiving
general anesthesia, 144 (2.1%) receiving regional anesthesia, and 115
(2.4%) receiving combined anesthesia. In the multivariable adjusted
analysis, when compared with general anesthesia the mortality risk did
not differ significantly between regional anesthesia (risk ratio 0.93, 95%
confidence interval 0.78 to 1.11) or combined anesthesia (1.00, 0.82 to
1.22). A mixed effects analysis accounting for differences between
hospitals produced similar results: compared with general anesthesia
the risk from regional anesthesia was 0.91 (0.75 to 1.10) and from
combined anesthesia was 0.98 (0.79 to 1.21). Findings were also
consistent in subgroup analyses.
Conclusions In this large nationwide sample of hospital admissions,
mortality risk did not differ significantly by anesthesia type among patients
undergoing hip fracture surgery. Our results suggest that if the previously
posited beneficial effect of regional anesthesia on short term mortality
exists, it is likely to be more modest than previously reported.
Introduction
Hip fractures are serious injuries, with an estimated annual
incidence of more than 1.5 million worldwide.
1 Owing to the
global increase of the population aged 65 years and over, the
total number of hip fractures is expected to surpass six million
by 2050.
2 In 2010 in the United States, there were 303 000
hospital admissions for hip fractures among adults.
3 Hip
fractures are associated with a substantial risk of morbidity and
mortality, with approximately 1-6% of patients dying during
hospitalstay
4-6and4-10%dyingwithin30daysofadmission,
4 6-8
largely due to high rates of pulmonary and cardiovascular
complications.
8 9 Most hip fractures are treated with surgical
repair, which represents one of the most common orthopedic
procedures.
10 Few interventions have been shown to decrease
mortality in patients with hip fracture.
11 12
Anesthesia type has been hypothesized to have an effect on
mortality among patients undergoing a range of surgical
procedures. Specific advantages associated with the different
anesthetic techniques may play a part in this effect. Regional
anesthesialeadstoavoidanceofairwaymanagement,decreased
blood loss, potentially reduced risk of deep venous thrombosis,
and improved postoperative analgesia. Conversely, general
anesthesia may be associated with a more stable hemodynamic
state than regional anesthesia.
10 13 14
Several investigations have attempted to determine whether
regional anesthesia offers benefits over general anesthesia for
surgeries generally, but evidence remains conflicting. In 2000
a meta-analyses of 141 clinical trials showed a reduction in
postoperative mortality associated with regional anesthesia,
with the subsequent recommendation for more widespread use
of neuraxial blockade.
15 However, most of the studies included
in this meta-analysis were small (<100 patients); were dated,
with many trials published in the 1980s; and often did not
distinguishbetweenregionalandcombinedgeneralandregional
anesthesia.
16 More recent meta-analyses of randomized clinical
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Research
RESEARCHstudies have produced mixed results and have not been able to
conclude if anesthetic type influences mortality.
17-20
For hip fracture surgery, two meta-analyses of 15 and 22
randomized clinical trials comparing regional with general
anesthesiafoundborderlinesignificantresultsofareducedshort
term risk of mortality associated with regional anesthesia, but
no evidence of a decreased risk at three months post-surgery or
beyond
10 21; all included studies had important methodological
flaws. A review of 34 clinical trials concluded that the limited
evidence available does not permit a definitive conclusion to
be drawn on type of anesthesia and mortality risk in patients
undergoing hip fracture surgery.
22 A few large observational
studies have been performed to assess the impact of anesthesia
type on mortality among such patients, with discordant results.
While some of these studies found that the use of regional
anesthesia was associated with a decreased risk of mortality,
5 6
others found no difference in outcomes.
4 23 We evaluated the
effect of anesthesia type on the risk of in-hospital mortality
among adults undergoing hip fracture surgery using the largest
nationwide database of inpatient hospital admissions, which
contains information on types of anesthesia available in the
United States.
Methods
Data source
We collected data from the Premier research database, which
contains data on healthcare utilization by inpatients from the
records of about one sixth of all hospital admissions in the
United States. Premier is a national organization focused on
healthcareperformanceimprovementthatprovidesdataservices
tohospitals,includingtabulationandbenchmarkingagainstthe
performance of other institutions, and its database records
information on all inpatients from approximately 500 hospitals
across the United States (numbers vary slightly by year). Data
are collected from member hospitals through Premier’s
informatics products, and Premier then provides information to
the hospitals for benchmarking purposes. All patients treated
at these hospitals are included in the database, independent of
payer status (Medicaid, Medicare, or commercial insurance).
The hospitals are primarily non-profit, non-governmental,
community and teaching hospitals.
The database also includes date stamped charges for all drugs,
procedures, and diagnostic tests during inpatient admissions
(charge codes). Patients’ personal and hospital characteristics,
dischargediagnoses,anddischargestatusarealsorecorded.The
database reflects all the information that is captured for billing
purposes at the hospital level; thus data are expected to be
accurate.Dataarealsoroutinelyaudited,verified,andvalidated
to ensure that the use of supplies and other hospital resources
are within an acceptable range, but Premier does not directly
verify that submitted data match individual patients’ medical
records.
24PreliminaryanalysisdonebythePremierorganization,
comparing characteristics of patients and hospitals for Premier
hospitals using the Premier research database with those from
the national hospital discharge survey suggests that the profile
of patients treated at hospitals participating in the Premier
researchdatabaseissimilartothosetreatednationally(statement
of work document, Premier, 2012). Several studies have used
Premier data to study perioperative drug use and health
outcomes.
24-27
Study population
The study population included adults aged 18 years and older
who underwent hip fracture surgery between 1 October 2007
and 30 September 2011.We identified surgical repair of hip
fracture based on a previous definition.
6 We selected all
discharges with a principal or a secondary diagnosis code for
hip fracture, including disease related fractures of the femoral
neck (international classification of disease, ninth revision,
clinicalmodification
28diagnosiscodes820,733.14);withinthis
group we restricted to patients with a procedure code
corresponding to open reduction, internal fixation,
hemiarthroplasty, or total hip arthroplasty (ICD-9-CM codes
00.7,79.15,79.25,79.35,81.40,81.51-3).Weexcludedpatients
undergoing closed reduction without internal fixation (79.05)
and those with an ICD-9-CM code suggestive of multiple
trauma, including other fractures (800-819, 821-829),
dislocations (830-839), sprains (840-848), injuries (850-854,
860-887, 925-929), and accidents (E800-E807, E810-E838,
E840-E848). For the main analysis, we included only those
patients who underwent surgical repair of hip fracture on the
second day of hospital admission or thereafter. We did this to
allow for a baseline period in which information on patients’
comorbiditiesandotherriskfactorswascollected;thesefactors
may affect both the choice of anesthesia type and the risk of
mortality and thus act as confounders.
Exposure and study outcome
We defined exposure to a specific anesthesia type by one or
more charge codes for general or regional anesthesia generated
onthedayofsurgery.Weclassifiedpatientsashavingreceived
general anesthesia if they had charges for general anesthesia
only, whereas we classified patients who had charges for
epidural or spinal anesthesia as having received regional
anesthesia. Study participants having charges for both general
and regional anesthesia were classified as having received
combinedgeneralandregionalanesthesia.Tolimitthechances
ofmisclassificationforexposure,weexcludedfromtheanalysis
those patients without a detailed and clear indication of
anesthesiatypeonthedayofsurgery(n=32149).Thesepatients
were not dissimilar from the other patients for characteristics
and risk of in-hospital mortality (see supplementary tables A1
and A2). An equivalent extent of inconclusive information on
anesthesia type has been previously observed with the Premier
research database.
29
The study outcome was in-hospital mortality as recorded in the
database. We chose in-hospital mortality as the study endpoint
becausetheimmediatepostoperativeperiodislikelytobemore
causally related to the type of anesthesia used during surgery
than in subsequent periods. In-hospital mortality was chosen as
primary outcome in a recent US observational study,
6 and a
sevendaymortalityoutcomehasbeenrecognizedasmorelikely
toreflectanestheticrelatedcomplicationsthanlongerfollow-up
periods.
4
Patient and hospital level characteristics
We identified the following patient and hospital level
characteristicsaspotentialconfounders:personalcharacteristics,
hospitalizationandsurgerycharacteristics,fracturetype,chronic
comorbidconditions,inpatientuseofdrugsandservicesbefore
the day of surgery, and hospital characteristics. Personal
characteristicsincludedageonadmission,sex,raceorethnicity
(white, black, hispanic, or other), and marital status (married,
single, or other). Hospitalization and surgery characteristics
included type of admission (emergency room, non-healthcare
facility,orother),yearofadmission,numberofdaysthepatient
was in hospital before surgery, and type of surgical procedure
(closed or open reduction of fracture, total or partial hip
replacement, other hip procedures). Using discharge diagnoses
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RESEARCHwe identified fracture type (transcervical, intertrochanteric,
subtrochanteric, other trochanteric fractures, fractures of
unspecified part of neck of femur, disease related fractures of
neck of femur) and presence of chronic comorbid conditions.
Chronic comorbid conditions included chronic hypertension,
diabetes,hyperlipidemia,chronicobstructivepulmonarydisease,
previousmyocardialinfarction,historyofpercutaneouscoronary
procedure, other forms of ischemic heart disease, chronic heart
failure, chronic cardiac dysrhythmia, previous stroke, renal
disease, liver disease, chronic hemostatic disorders, dementia,
cancer, osteoarthritis, rheumatoid arthritis, obesity, smoking
(former or current), alcohol or drug misuse or dependence, and
history of peptic ulcer disease. Although these conditions were
recorded as discharge diagnoses, all these chronic conditions
would have been present before admission. We also calculated
the Romano modification of the Charlson comorbidity index
for each patient by using conditions identified by discharge
diagnoses.
30 We evaluated charges for drugs and procedures
before the day of surgery as markers of severity of comorbid
illness. Charges for drug use included angiotensin converting
enzyme inhibitors, angiotensin receptor blockers, β blockers,
calcium channel blockers, nitrates, thiazide diuretics, loop
diuretics,aldosteroneantagonists,digoxin,rhythmcontroldrugs,
oral antidiabetes drugs or insulin, treatment for chronic
obstructive respiratory diseases (inhaled β2 agonists, inhaled
steroids, leukotriene inhibitors, ipratropium, or theophylline),
statins, aspirin, other antiplatelets, warfarin, subcutaneous
anticoagulants, intravenous heparin, and systemic
corticosteroids. We also assessed charges for inpatient services
beforesurgery,includingpreoperativeadmissiontoanintensive
care unit, oxygen use, telemetry, echocardiography, dialysis,
transfusion of packed red blood cells, and transfusion of fresh
frozen plasma. Finally, we assessed the characteristics of the
hospitals in which patients were treated and recorded whether
they were teaching hospitals and whether they were located in
anurbanorrurallocation.Weestimatedtheannualizedvolume
of surgeries for hip fracture repair performed by each hospital
by dividing the total number of such surgeries for each hospital
duringthestudyperiodbythenumberofyearsthateachhospital
performed one or more surgical repairs for hip fracture. We
ranked hospitals in order of annualized volume and then
categorized them into thirds of volume (high, medium, and low
volume hospitals).
31 We classified the region of the hospital as
mid-west, north east, south, or west.
Statistical analysis
Wecrosstabulatedpatientcharacteristicsbytypeofanesthesia.
For each anesthesia type, we calculated number of patients,
number of events, and the in-hospital mortality risk. We
determined the unadjusted risk ratios with 95% confidence
intervals for in-hospital mortality, comparing patients exposed
to regional anesthesia and combined general and regional
anesthesiawithpatientsexposedtogeneralanesthesia.Because
of the low event rate, we report the odds ratios from logistic
regression analyses as risk ratios.
32
Tocontrolforconfoundingbyindication,wefitamultivariable
logistic regression model, from which we estimated a relative
risk and 95% confidence interval for in-hospital mortality. The
model included all personal, hospital admission, and surgery
characteristics, fracture types, chronic comorbid conditions,
inpatient use of drugs and services before the day of surgery,
and hospital characteristics, as defined previously.
To test the robustness of our primary findings we performed
several sensitivity analyses. Firstly, we used mixed effects
logistic regression models to compare anesthetic technique,
adjusting for potential differences between hospitals. The
hospital identifying variable was modeled as a normally
distributed random intercept, and the patient and hospital level
characteristics were modeled as fixed effects variables. This
analysis provided information about the effect of anesthesia
type on mortality risk after having adjusted for the individual
hospital effect. Secondly, to test the generalizability of our
findings, we reassessed the risk of in-hospital mortality after
having extended the study cohort to include all patients
undergoing hip fracture surgery independently of when the
surgical procedure took place during the hospital admission,
thusincludingalsothepatientswhohadsurgeryonthefirstday
of hospital admission. Although important in establishing
generalizability, estimates from these analyses are more likely
to be biased than those obtained in the primary analysis owing
to more limited ability to control for confounding (as less
baseline information is available before surgery). For this
analysis, the multivariable logistic regression model included
onlypersonal,admissiontohospital,andsurgerycharacteristics,
fracture types, chronic comorbid conditions, and hospital
characteristics. Thirdly, we tested the potential for effect
modificationinsubgroupanalysesrestrictedtopatients75years
and older and to patients with no recorded diagnosis of cancer
at discharge.
StatisticalanalyseswereperformedusingSASversion9.3(SAS
Institute, Cary, NC).
Results
Overall, 73 284 patients underwent surgery for hip fracture
repairbetween1October2007and30September2011andhad
informationonthetypeofanesthesiareceived.Ofthose,61554
(84.0%) received general anesthesia, 6939 (9.5%) received
regionalanesthesia,and4791(6.5%)receivedbothgeneraland
regional anesthesia (figure⇓). Hospital length of stay after
surgery was equivalent across the three anesthetic groups
(median five days), thus providing an equal opportunity to
observeoutcomesinallthegroups.Intotal,1621(2.2%)deaths
occurred during hospital admission, which is consistent with
previously reported findings.
4 6
Baselinecharacteristicsweregenerallysimilaracrossanesthetic
groups(table1⇓),withafewdifferencesnoted.Comparedwith
patients receiving other types of anesthesia, those receiving
generalanesthesiawereyounger,lesslikelytobewomen,more
likelytobeadmittedfromanon-healthcarefacility,morelikely
to undergo closed or open fracture reduction, and less likely to
undergo partial hip replacement; they had a lower frequency of
transcervicalfracturesandmoreoftenhaddiabetesbutlessoften
had a history of chronic obstructive pulmonary disease or
dementia.Patientsreceivinggeneralanesthesiaweremorelikely
to have received treatment with β blockers, antidiabetes drugs,
and statins, to have been admitted to an intensive care unit, or
to have had dialysis, and were less likely to have received
supplementaloxygenbeforesurgery.Thesepatientsweremore
often treated at teaching and urban hospitals and at hospitals in
the north east and mid-west. Conversely, patients receiving
regional anesthesia were older, more likely to be women, more
likely to be admitted through the emergency department, less
likely to have white or black ethnicity, and less likely to have
chronic renal disease.
Overall, 1362 (2.2%) in-hospital deaths occurred in patients
receiving general anesthesia, 144 (2.1%) in patients receiving
regional anesthesia, and 115 (2.4%) in patients receiving
combinedanesthesia(table2⇓).Theunadjustedanalysesshowed
no significant differences in the risk of in-hospital mortality
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RESEARCHacross the anesthetic groups for patients receiving regional
anesthesia compared with general anesthesia (risk ratio 0.94,
95% confidence interval 0.79 to 1.11) or combined anesthesia
comparedwithgeneralanesthesia(1.09,0.90to1.32).Similarly,
inthemultivariableanalysistherewasnostatisticallysignificant
difference in mortality risk associated with the use of either
regional compared with general anesthesia (0.93, 0.78 to 1.11)
or combined compared with general anesthesia (1.00, 0.82 to
1.22).
The mixed effects analysis, which accounted for differences
betweenhospitals,producedresultsconsistentwiththoseofthe
main analysis (regional v general anesthesia 0.91, 0.75 to 1.10,
and combined v general anesthesia 0.98, 0.79 to 1.21). When
thestudypopulationwasextendedtoincludethosepatientswho
had surgery on the first day of hospital admission, the results
remained consistent (regional v general anesthesia 0.91 (0.77
to 1.08), and combined v general anesthesia 0.97 (0.82 to 1.17,
table 3⇓). Similarly, restricting the study population to patients
with no diagnosis of cancer at discharge or to patients 75 years
and older yielded a similar effect for regional or combined
anesthesia compared with general anesthesia (table 3).
Discussion
Using a cohort of 73 284 adult who underwent surgery for hip
fracture in a nationwide sample of inpatient admissions in the
United States, we found no evidence of a significant difference
in the risk of in-hospital mortality associated with type of
anesthesia. This result was robust across several sensitivity and
subgroup analyses. However, we observed a not statistically
significant7%to9%reductioninmortalityriskassociatedwith
the use of regional anesthesia alone compared with general
anesthesia,whichdoesnotpermittherulingoutofthepossibility
of a modest beneficial effect in the routine care of patients
undergoing hip fracture surgery.
Comparison with other studies
Whetherthereisabeneficialeffectonmortalityassociatedwith
the use of regional anesthesia has been an area of considerable
controversy. Previous meta-analyses of randomized clinical
trials
10 21foundanon-significantorborderlinesignificanteffect
of regional anesthesia in reducing short term mortality among
patients undergoing hip fracture surgery; however, all included
trials had important methodological flaws. Similarly, a
retrospective cohort study of 9425 patients aged 60 years and
older who underwent surgical repair of hip fracture at 20 US
hospitals between 1983 and 1993 found no difference between
general and regional anesthesia for seven or 30 day mortality
risk.
4 Conversely, two subsequent observational studies found
that the use of regional anesthesia was associated with a
substantial decreased risk of mortality: Redcliff and colleagues
found that in a cohort of 5683 community dwelling male
veterans undergoing hip fracture surgery between 1998 and
2003, general anesthesia was associated with a 27% increased
risk of 30 day mortality compared with regional anesthesia
5;
Neuman and colleagues found that regional anesthesia was
associated with a 29% reduced risk of in-hospital mortality
compared with general anesthesia among 18 158 patients
undergoing surgical repair of hip fracture at 126 hospitals in
NewYorkStatebetween2007and2008.
6Morerecently,alarge
observational study based on 57 397 patients who underwent
hip fracture surgery in the United Kingdom in 2012 and had
available information on anesthesia type and vital status, found
no difference in the age and American Society of
Anesthesiologistsphysicalstatusadjusted30daymortalityrisk
between general and spinal anesthesia.
23 The results from our
observational study, which derive from a cohort that is
substantially larger than in these previous studies (allowing for
more precise estimates), which account for many more
comorbidities and their proxies using granular data (allowing
for superior confounding control), and which are based on
anesthesia type defined by charge codes (which results in
minimal misclassification of exposure), suggest that there is
either little or no effect of regional anesthesia on the risk of
mortality after hip fracture surgery. If a beneficial effect of
regional anesthesia on short term mortality exists, it is likely to
be more modest than previously reported.
Strengths and limitations of this study
Our study has several strengths. To our knowledge, this is the
largest population based study to evaluate the effect of
anesthesia type on the risk of mortality among patients
undergoing hip fracture surgery in a routine care setting using
data from a nationwide sample. Through the use of the Premier
research database, we were able to access detailed inpatient
information, including drug treatment, procedure utilization,
and patients’ diagnoses. We used multiple approaches in the
design and analysis of the study to minimize the potential for
residual confounding, including the restriction to patients who
hadhipfracturesurgeryontheseconddayofhospitaladmission
orthereafter,toallowforabaselineperiodinwhichinformation
on comorbidities and their proxies could be collected, and the
use of mixed effects logistic analysis to account for potential
differences associated with individual hospitals. We also
investigated the potential for effect modification in subgroup
analyses restricted to patients 75 years and older and to patients
with no recorded diagnosis of cancer at discharge. Further, we
capture the type of anesthesia based on charge codes, which
should result in minimal misclassification of exposure.
Some limitations need to be considered. Although the Premier
researchdatabaseprovidesdetailedinpatientinformation,certain
relevant clinical details (for example, functional status before
the injury, measures of frailty, pulmonary function, body mass
index) might not have been completely captured, as either not
fully or not directly measured in administrative data, and thus
mayleadtoresidualconfounding.Weadjustedforconfounding
by restricting the study population to the patients who had
surgery on hospital day 2 or later to identify and adjust for all
relevant confounders and their proxies that might be associated
with the choice of anesthesia type, and by using mixed effects
analysis to account for potential differences between hospitals
that might confound the association between anesthesia type
and in-hospital mortality. Despite these efforts, some residual
confoundingispossible;however,fortheretobeasubstantially
beneficial effect of regional anesthesia, the amount of residual
confounding would need to be implausibly large given the
detailed patient level data available in the Premier research
database. An additional limitation is that about 30% of the
patients undergoing hip fracture surgery had no conclusive
information on the type of anesthesia through the database, as
previously observed.
29 To ensure a highly specific definition of
anesthesia type, we excluded those patients. However, patient
andhospitallevelcharacteristicsaswellasin-hospitalmortality
risk were not dissimilar between patients with and without
conclusive information on anesthesia type (see supplementary
tables A1 and A2), suggesting that their exclusion is unlikely
to affect our findings. Although all fully adjusted models
controlled for dementia, a further limitation is the absence of
accurateinformationforpossiblepatientdeliriumonadmission,
which can be associated with the choice of anesthesia type and
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RESEARCHthe risk of mortality. This is because the Premier research
database collects information on ICD-9 diagnosis codes only
at discharge and therefore does not discriminate between
delirium that occurred on admission or subsequent to the hip
surgery procedure. Another potential limitation is that to
measure and account for baseline clinical characteristics that
might influence the choice of anesthesia type, we restricted our
principal analysis to patients who had surgery on hospital day
2 or later, which may affect the generalizability of our results.
To tackle this potential problem, in a sensitivity analysis we
examined the risk of in-hospital mortality including patients
who had surgery on any day during their hospital admission.
All the analyses yielded consistent results, suggesting that our
findingsaregeneralizabletoallpatientsundergoinghipfracture
surgery. Finally, while our results suggest the use of regional
anesthesiaintheUnitedStatesislesscommonthaninEurope,
23
this difference alone should not impact on the causal effect of
anesthesia type on mortality and thus on the generalizability of
our results to non-US settings.
Conclusions
The findings from this large nationwide investigation do not
support the hypothesis of a substantially beneficial effect of
regional anesthesia compared with general anesthesia on all
causemortality,butsuggestthatifabeneficialeffectofregional
anesthesia on postoperative mortality exists, it is likely to be
moremodestthanpreviouslyreported.Additionalresearchwith
studies powered to detect effect heterogeneity is needed to
explore if specific population subgroups may meaningfully
benefit from the use of regional anesthesia. Based on our data,
the choice of anesthesia type should put emphasis on
considerations other than differences in short term mortality.
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RESEARCHWhat is already known on this topic
Hip fractures are common and serious injuries characterized by high morbidity and mortality risk; surgical repair is generally indicated
Few interventions have been shown to decrease mortality in patients with hip fracture
The use of regional anesthesia has been hypothesized to reduce the risk of postoperative mortality among patients undergoing hip
fracture surgery, but findings remain conflicting
What this study adds
In this study of a large nationwide sample of inpatient admissions in the United States, mortality risk did not differ significantly by
anesthesia type among patients undergoing surgical repair of hip fracture
If the previously posited beneficial effect of regional anesthesia on postoperative mortality exists, it is likely to be more modest than
previously reported
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on different terms, provided the original work is properly cited and the use is
non-commercial. See: http://creativecommons.org/licenses/by-nc/3.0/.
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RESEARCHTables
Table 1| Selected baseline characteristics of study patients receiving general, regional, or combined general and regional anesthesia.
Values are numbers (percentages) unless stated otherwise
Anesthesia type
Characteristics General and regional (n=4791) Regional (n=6939) General (n=61 554)
Personal characteristics
83 (76-88) 83 (77-88) 82 (74-88) Median (interquartile range) age (years)
Age groups (years):
88 (1.8) 99 (1.4) 2235 (3.6) 18-54
531 (11.1) 681 (9.8) 8224 (13.4) 55-69
1107 (23.1) 1581 (22.8) 13 941 (22.6) 70-79
1026 (21.4) 1540 (22.2) 12 830 (20.8) 80-84
2039 (42.6) 3038 (43.8) 24 324 (39.5) ≥85
3429 (71.6) 5063 (73.0) 43 527 (70.7) Women
Ethnicity:
4084 (85.2) 5068 (73.0) 48 768 (79.2) White
247 (5.2) 211 (3.0) 2949 (4.8) Black
39 (0.8) 594 (8.6) 1938 (3.1) Hispanic
421 (8.8) 1066 (15.4) 7899 (12.8) Other or unknown
Hospitalization and surgery characteristics
Type of admission:
2676 (55.9) 4322 (62.3) 34 852 (56.6) Emergency room
1342 (28.0) 1817 (26.2) 18 554 (30.1) Non-healthcare facility
773 (16.1) 800 (11.5) 8148 (13.3) Other*
1 (1-2) 1 (1-2) 1 (1-2) Median (interquartile range) days before
surgery
Type of surgical procedure:
1047 (21.9) 1483 (21.4) 14 359 (23.3) Closed reduction of fracture
1470 (30.7) 2398 (34.6) 21 541 (35.0) Open reduction of fracture
232 (4.8) 297 (4.3) 2622 (4.3) Total hip replacement
2067 (43.1) 2790 (40.2) 23 252 (37.8) Partial hip replacement
336 (7.0) 362 (5.2) 3598 (5.9) Other hip procedure
Comorbidities
Type of fracture:
1332 (27.8) 1974 (28.4) 15 951 (25.9) Transcervical fracture
1941 (40.5) 2988 (43.1) 26 874 (43.7) Intertrochanteric fracture
243 (5.1) 365 (5.3) 3831 (6.2) Subtrochanteric fracture
106 (2.2) 152 (2.2) 1299 (2.1) Trochanteric fracture
1978 (41.3) 2680 (38.6) 23 754 (38.6) Unspecified part of neck of femur
111 (2.3) 168 (2.4) 1813 (2.9) Disease related fracture of neck of femur
1 (0-2) 1 (0-2) 1 (0-2) Median (interquartile range) Charlson
comorbidity score
3499 (73.0) 5014 (72.3) 44 521 (72.3) Chronic hypertension
1049 (21.9) 1508 (21.7) 14 877 (24.2) Diabetes
378 (7.9) 568 (8.2) 4966 (8.1) Previous myocardial infarction
838 (17.5) 1166 (16.8) 11 020 (17.9) Chronic heart failure
1070 (22.3) 1577 (22.7) 11 216 (18.2) Chronic obstructive pulmonary disease
833 (17.4) 1023 (14.7) 10 513 (17.1) Chronic renal disease
1459 (30.5) 2081 (30.0) 17 254 (28.0) Dementia
303 (6.3) 405 (5.8) 4191 (6.8) Cancer
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Anesthesia type
Characteristics General and regional (n=4791) Regional (n=6939) General (n=61 554)
Inpatient use of drugs and services before surgery
673 (14.0) 933 (13.4) 8937 (14.5) Angiotensin converting enzyme inhibitor
1582 (33.0) 2258 (32.5) 21 362 (34.7) β blocker
710 (14.8) 1020 (14.7) 9113 (14.8) Calcium channel blocker
175 (3.7) 254 (3.7) 2391 (3.9) Nitrates
676 (14.1) 878 (12.7) 8532 (13.9) Loop diuretics
664 (13.9) 919 (13.2) 9043 (14.7) Antidiabetes drugs
974 (20.3) 1285 (18.5) 13 526 (22.0) Statin
355 (7.4) 393 (5.7) 4166 (6.8) Aspirin
26 (0.5) 25 (0.4) 374 (0.6) Warfarin
61 (1.3) 81 (1.2) 900 (1.5) Intravenous heparin
259 (5.4) 432 (6.2) 4767 (7.7) Intensive care unit admission
1267 (26.4) 1741 (25.1) 12 568 (20.4) Oxygen use
68 (1.4) 104 (1.5) 1254 (2.0) Dialysis
Packed red blood cells transfusion:
4290 (89.5) 6393 (92.1) 55 024 (89.4) 0 unit
139 (2.9) 202 (2.9) 2010 (3.3) 1 unit
362 (7.6) 344 (5.0) 4520 (7.3) ≥ 2 units
Hospital characteristics
1273 (26.6) 1318 (19.0) 22 114 (35.9) Teaching hospital
3650 (76.2) 5805 (83.7) 54 790 (89.0) Urban hospital
Age and Charlson comorbidity score were modeled as categorical variables in the multivariable logistic models. Additional covariates that were included in the
multivariable logistic models include marital status; year of admission; hyperlipidemia; history of percutaneous coronary procedure; other forms of ischemic heart
disease; chronic cardiac dysrhythmia; previous stroke; liver disease; chronic hemostatic disorders; osteoarthritis; rheumatoid arthritis; obesity; smoking (former or
current); alcohol or drug misuse or dependence; history of peptic ulcer disease; unintentional fall; angiotensin receptor blockers, thiazide diuretics; aldosterone
antagonists; digoxin; rhythm control drugs; treatment for chronic obstructive respiratory diseases (inhaled β2 agonists, inhaled steroids, leukotriene inhibitors,
ipratropium, or theophylline); other antiplatelets; subcutaneous anticoagulants; systemic corticosteroids; telemetry; echocardiography; fresh frozen plasma
transfusion; thirds of hip fracture surgery volume; and region.
*Includes admission from clinic; admission from court or law enforcement; transfer from ambulatory surgery center; transfer from another home health agency;
transfer from same hospital, separate claim; transfer from other healthcare facility; transfer from hospice; transfer from skilled nursing facility or intermediate care
facility; transfer from a hospital (different facility); information not available.
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confidence intervals) unless stated otherwise
General and regional anesthesia Regional anesthesia General anesthesia Variables
4791 6939 61 554 No of patients
115 144 1362 No of in-hospital deaths
2.4 2.1 2.2 Risk of in-hospital death (%)
1.09 (0.90 to 1.32) 0.94 (0.79 to 1.11) Ref Unadjusted analysis
1.04 (0.85 to 1.26) 0.93 (0.78 to 1.11) Ref Adjusted analysis*
1.00 (0.82 to 1.22) 0.93 (0.78 to 1.11) Ref Fully adjusted analysis†
0.98 (0.79 to 1.21) 0.91 (0.75 to 1.10) Ref Mixed effects analysis‡
*Adjusted for age, sex, ethnicity, and calendar year.
†Included all covariates noted in table 1.
‡Hospital identifying variable was modeled as a normally distributed random intercept, and patient and hospital level characteristics were modeled as fixed effects
variables.
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RESEARCHTable 3| Sensitivity analyses: number of events and risk of in-hospital mortality in patients receiving different types of anesthesia. Values
are risk ratios (95% confidence intervals) unless stated otherwise
General and regional anesthesia Regional anesthesia General anesthesia Variables
Patients undergoing hip fracture surgery independently of surgical
procedure timing:
6843 9079 79 915 No of patients
142 167 1607 No of in-hospital deaths
2.1 1.8 2.0 Risk of in-hospital death (%)
1.03 (0.87 to 1.23) 0.91 (0.78 to 1.07) Ref Unadjusted analysis
0.98 (0.82 to 1.16) 0.89 (0.76 to 1.05) Ref Adjusted analysis*
0.97 (0.82 to 1.17) 0.91 (0.77 to 1.08) Ref Fully adjusted analysis†
Patients with no recorded diagnosis of cancer at discharge:
3856 5565 49 648 No of patients
86 110 1035 No of in-hospital deaths
2.2 2.0 2.1 Risk of in-hospital death (%)
1.07 (0.86 to 1.34) 0.95 (0.78 to 1.16) Ref Unadjusted analysis
1.01 (0.81 to 1.27) 0.94 (0.77 to 1.14) Ref Adjusted analysis*
0.97 (0.77 to 1.22) 0.93 (0.76 to 1.15) Ref Fully adjusted analysis
Patients aged 75 years and older:
3753 5564 45 709 No of patients
96 126 1154 No of in-hospital deaths
2.6 2.3 2.5 Risk of in-hospital death (%)
1.01 (0.82 to 1.25) 0.89 (0.74 to 1.08) Ref Unadjusted analysis
0.99 (0.80 to 1.22) 0.94 (0.78 to 1.13) Ref Adjusted analysis*
0.95 (0.77 to 1.18) 0.92 (0.76 to 1.12) Ref Fully adjusted analysis
*Adjusted for age, sex, ethnicity, and calendar year.
†Includes all covariates noted in table 1 except for inpatient use of drugs and services before day of surgery.
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Flowchart of study cohort
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